Santen Pharmaceutical Co., Ltd. (TYO:4536)

Santen Pharmaceutical Revenue

Santen Pharmaceutical had revenue of 69.14B JPY in the quarter ending September 30, 2025, a decrease of -3.48%. This brings the company's revenue in the last twelve months to 291.48B, down -3.66% year-over-year. In the fiscal year ending March 31, 2025, Santen Pharmaceutical had annual revenue of 300.00B, down -0.65%.

• Revenue (ttm): 291.48B
• Revenue Growth: -3.66%
• P/S Ratio: 1.78
• Revenue / Employee: 75.73M
• Employees: 3,849
• Market Cap: 519.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	300.00B	-1.96B	-0.65%
Mar 31, 2024	301.97B	22.93B	8.22%
Mar 31, 2023	279.04B	12.78B	4.80%
Mar 31, 2022	266.26B	16.65B	6.67%
Mar 31, 2021	249.61B	8.05B	3.33%